Schedule 13D ownership disclosure
FORTRESS BIOTECH INC
Security class unavailable · CUSIP: 34960Q307
Event date: 2023-11-14
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 17.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-23-120355
- Form type
- SC 13D
- Filer
- Fortress Biotech, Inc.
- CIK
- CIK 1429260
- Filed
- Nov 21, 2023
- Reporting period
- Nov 14, 2023
- Description
- Schedule 13D beneficial ownership